# Achim A. Jungbluth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/achim-a-jungbluth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,200 |
| Field | Immunotherapy and Immune Responses |
| h-index | 99 |
| i10-index | 267 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5009105564 |
| ORCID iD | https://orcid.org/0000-0002-8949-2333 |
| Works | 551 |

## Researcher papers

- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Integrative Molecular Characterization of Malignant Pleural Mesothelioma](https://scholariq.org/papers/integrative-molecular-characterization-of-malignant-pleural-mesothelioma/)
- [CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma](https://scholariq.org/papers/cd8-tumor-infiltrating-lymphocytes-are-predictive-of-survival-in-muscle-invasive/)
- [SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization](https://scholariq.org/papers/sclc-subtypes-defined-by-ascl1-neurod1-pou2f3-and-yap1-a-comprehensive/)
- [Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans](https://scholariq.org/papers/recombinant-ny-eso-1-protein-with-iscomatrix-adjuvant-induces-broad-integrated/)
- [Anti-CTLA-4 therapy results in higher CD4 <sup>+</sup> ICOS <sup>hi</sup> T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues](https://scholariq.org/papers/anti-ctla-4-therapy-results-in-higher-cd4-sup-sup-icos-sup-hi-sup-t-cell/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.